InvestorsHub Logo

DavidW2

09/18/17 3:48 PM

#7613 RE: mazlat10 #7612

ACAD was at $5-$6 because company thought they need to do SECOND P3 trial. FDA notified ACAD there is no need to do another P3 trial. Stock jumped to $12 then quickly moved to $20 in 1-2 weeks.